KR20160006788A - 디카복실산으로 에스테르화된 셀룰로스 에테르 - Google Patents

디카복실산으로 에스테르화된 셀룰로스 에테르 Download PDF

Info

Publication number
KR20160006788A
KR20160006788A KR1020157035306A KR20157035306A KR20160006788A KR 20160006788 A KR20160006788 A KR 20160006788A KR 1020157035306 A KR1020157035306 A KR 1020157035306A KR 20157035306 A KR20157035306 A KR 20157035306A KR 20160006788 A KR20160006788 A KR 20160006788A
Authority
KR
South Korea
Prior art keywords
esterified cellulose
esterified
cellulose ether
group
hpmc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020157035306A
Other languages
English (en)
Korean (ko)
Inventor
리겅 인
마크 에이. 힐미어
스티븐 제이. 길로듀
로버트 엘. 슈미트
Original Assignee
다우 글로벌 테크놀로지스 엘엘씨
리젠츠 오브 더 유니버시티 오브 미네소타
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 다우 글로벌 테크놀로지스 엘엘씨, 리젠츠 오브 더 유니버시티 오브 미네소타 filed Critical 다우 글로벌 테크놀로지스 엘엘씨
Publication of KR20160006788A publication Critical patent/KR20160006788A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B13/00—Preparation of cellulose ether-esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020157035306A 2013-05-14 2014-05-07 디카복실산으로 에스테르화된 셀룰로스 에테르 Ceased KR20160006788A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361822977P 2013-05-14 2013-05-14
US61/822,977 2013-05-14
PCT/US2014/037070 WO2014186185A1 (en) 2013-05-14 2014-05-07 Cellulose ethers esterified with dicarboxylic acids

Publications (1)

Publication Number Publication Date
KR20160006788A true KR20160006788A (ko) 2016-01-19

Family

ID=50977076

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020157035306A Ceased KR20160006788A (ko) 2013-05-14 2014-05-07 디카복실산으로 에스테르화된 셀룰로스 에테르

Country Status (7)

Country Link
US (1) US9890221B2 (enExample)
EP (1) EP2997046B1 (enExample)
JP (1) JP6306691B2 (enExample)
KR (1) KR20160006788A (enExample)
CN (1) CN105164162B (enExample)
BR (1) BR112015024522A8 (enExample)
WO (1) WO2014186185A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6683561B2 (ja) * 2016-07-12 2020-04-22 信越化学工業株式会社 腸溶性硬カプセル用組成物及び腸溶性硬カプセルの製造方法
CN112704671B (zh) * 2020-12-28 2022-04-19 普洛药业股份有限公司 一种阿莫西林克拉维酸钾胶囊及其制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4226981A (en) 1977-09-28 1980-10-07 Shin-Etsu Chemical Co., Ltd. Ether-ester derivatives of cellulose and their applications
DE2917104A1 (de) 1979-04-27 1980-11-06 Hoechst Ag Verfahren zur viskositaetserniedrigung von celluloseethern durch ozon und seine verwendung
JPS607492B2 (ja) * 1979-04-28 1985-02-25 信越化学工業株式会社 腸溶性カプセル
JPS5632424A (en) * 1979-08-27 1981-04-01 Shin Etsu Chem Co Ltd Preparation of formed enteric product
US4365060A (en) * 1979-04-28 1982-12-21 Shin-Etsu Chemical Co. Ltd. Enterosoluble capsules
JPS6225101A (ja) 1985-07-24 1987-02-03 Shin Etsu Chem Co Ltd 低重合度セルロ−スエ−テルの製造方法
JPS6281402A (ja) 1985-10-07 1987-04-14 Shin Etsu Chem Co Ltd セルロ−スエ−テル酸性ジカルボン酸エステルの製造方法
DE3620991A1 (de) 1986-06-23 1988-01-14 Henkel Kgaa Wasserloesliche alkenyl- oder alkylbernsteinsaeureester enthaltende celluloseether
DE4404840A1 (de) * 1994-02-16 1995-08-17 Wolff Walsrode Ag Thermoplastische biologisch abbaubare Polysaccharidderivate, Verfahren zu ihrer Herstellung und ihre Verwendung
DE19529409A1 (de) 1995-08-10 1997-02-13 Wolff Walsrode Ag Maleinsäureadditionsproduktgruppen enthaltende, thermoplastische und biologisch abbaubare Polysaccharidester/-etherester
EP0872233A1 (en) 1997-04-14 1998-10-21 Janssen Pharmaceutica N.V. Antiretroviral compositions with improved bioavailability
US6261218B1 (en) 1998-12-01 2001-07-17 The Dow Chemical Company Process and apparatus for making low molecular weight cellulose ethers
WO2000078285A1 (en) * 1999-06-18 2000-12-28 University Of Medicine And Dentistry Of New Jersey Controlled release of therapeutics by in-situ entrapment by matrix cross-linking
US20020076443A1 (en) * 2000-06-19 2002-06-20 Stanley Stein Multiple phase cross-linked compositions and uses thereof
DE10141680B4 (de) 2001-08-25 2004-02-26 Clariant Gmbh Verfahren zur Herstellung niederviskoser Celluloseether durch sauer-oxidativen Abbau von gemahlenen und getrockneten Celluloseethern
JP2003073443A (ja) * 2001-08-31 2003-03-12 Hiroshi Takimoto 生分解性高吸水性樹脂
JP2003160694A (ja) * 2001-11-28 2003-06-03 Hiroshi Takimoto 生分解性組成物
MXPA06013891A (es) 2004-05-28 2007-01-26 Pfizer Prod Inc Composiciones farmaceuticas con comportamiento potenciado.
EP2325247B1 (en) 2007-11-09 2014-10-08 Dow Global Technologies LLC Cellulose ether coating compositions and method
CN101855247B (zh) 2007-11-09 2013-03-20 联合碳化化学品及塑料技术公司 制备非常低粘度的纤维素醚的方法和产品
CN102933615B (zh) * 2010-06-08 2015-08-12 陶氏环球技术有限责任公司 制备粒状可逆交联的聚合物材料的方法
JP5792807B2 (ja) 2010-06-14 2015-10-14 ダウ グローバル テクノロジーズ エルエルシー アセテートおよびサクシネートの置換が向上されたヒドロキシプロピルメチルセルロースアセテートサクシネート
WO2013154607A1 (en) * 2012-04-11 2013-10-17 Dow Global Technologies Llc Esterified cellulose ethers having a specific substituent distribution
CN102807625A (zh) * 2012-08-23 2012-12-05 浙江中维药业有限公司 一种醋酸羟丙甲纤维素琥珀酸酯的制备方法

Also Published As

Publication number Publication date
CN105164162B (zh) 2017-11-28
EP2997046A1 (en) 2016-03-23
US9890221B2 (en) 2018-02-13
US20160289344A1 (en) 2016-10-06
BR112015024522A8 (pt) 2019-12-10
JP6306691B2 (ja) 2018-04-04
CN105164162A (zh) 2015-12-16
JP2016519198A (ja) 2016-06-30
WO2014186185A1 (en) 2014-11-20
EP2997046B1 (en) 2019-09-25
BR112015024522A2 (enExample) 2017-08-22

Similar Documents

Publication Publication Date Title
JP6321688B2 (ja) 低粘度の新規エステル化セルロースエーテル
KR102110119B1 (ko) 저점도 및 고분자량의 신규한 에스테르화된 셀룰로스 에테르
JP6334574B2 (ja) 新規の超高分子量のエステル化セルロースエーテル
KR102138546B1 (ko) 부분적으로 가교결합된 에스테르화된 셀룰로즈 에테르
KR101661952B1 (ko) 극저점도의 신규한 에스테르화된 셀룰로스 에테르
JP6420520B2 (ja) 新規の高分子量及び高均一性のエステル化セルロースエーテル
KR20150045511A (ko) 고분자량 및 높은 균일성을 갖는 신규한 에스테르화된 셀룰로즈 에테르
JP6795587B2 (ja) 分散されたエステル化セルロースエーテルを含む水性組成物
JP6356923B2 (ja) 水溶性エステル化セルロースエーテル
US9890221B2 (en) Cellulose ethers esterified with dicarboxylic acid
KR20170128350A (ko) 에스테르화된 셀룰로오스 에테르의 수용액

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20151211

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20190503

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20201117

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20210127

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20201117

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I